Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
APVOCompany Name
APTEVO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQAPTEVO THERAPEUTICS INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
APVO - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 265K | 0% | $ 0 |
| 3/31/2025 | $ 307K | 0% | $ 0 |
| 12/31/2024 | $ 352K | 0% | $ 0 |
| 9/30/2024 | $ 397K | 0% | $ 0 |
| 6/30/2024 | $ 436K | 0% | $ 0 |
| 3/31/2024 | $ 495K | 0% | $ 0 |
| 12/31/2023 | $ 567K | 0% | $ 0 |
| 9/30/2023 | $ 612K | 0% | $ 0 |
| 6/30/2023 | $ 711K | 0% | $ 0 |
| 3/31/2023 | $ 837K | 0% | $ 0 |
Key Performance Insights, Last 5 Years
- APTEVO THERAPEUTICS INC's latest trailing twelve months (TTM) DepAmor % stands at 14.56%.
- Over the past 5 years, APTEVO THERAPEUTICS INC's average DepAmor % has been 16.22%.
- The median DepAmor % for APTEVO THERAPEUTICS INC during this period was 13.85%
- APTEVO THERAPEUTICS INC reached its highest DepAmor % over the past 5 years at 32.63%.
- The lowest DepAmor % recorded by APTEVO THERAPEUTICS INC in the same timeframe 8.45%
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for APTEVO THERAPEUTICS INC is calculated as follows: DepAmor [ $ 1.6M ] / Revenues [ $ 10.97M ]
(=) DepAmor % [ 14.56% ] APVO - Depreciation and Amortization Margin, Last 5 years
8.45%
Minimum
Mar 31, 2022
32.63%
Maximum
Dec 31, 2020
16.22%
Average
13.85%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.12%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.31K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.22% |
| std | 5.12% |